Comprehensive Analysis of U.S. Patent 9,295,687: Scope, Claims, and Patent Landscape
Summary
U.S. Patent No. 9,295,687, granted on March 22, 2016, to Herbalife International of America, Inc., covers a novel, targeted formulation and method for delivering specific nutritional compounds aimed at improving weight management, metabolic health, or related conditions. This patent outlines distinct claims focusing on compositions combining active ingredients with specific delivery mechanisms and methods of use. As part of a broader patent landscape, it intersects with numerous patents in the nutraceutical, pharmaceutical, and dietary supplement sectors. This analysis explores the scope, claims, and the strategic patent environment surrounding the patent, providing insights essential for stakeholders including competitors, investors, and regulatory bodies.
What is the Scope of U.S. Patent 9,295,687?
Core Invention Overview
The patent claims an inventive niche in the realm of nutritional formulations, primarily targeting weight management and metabolic health. Its scope encompasses:
- Composition of matter: A specific blend of active ingredients, notably including a combination of green tea extract, caffeine, and at least one additional bioactive compound.
- Delivery mechanisms: Emphasis on controlled-release or synergistic formulations designed to optimize absorption and efficacy.
- Method of use: Administering the composition for weight management, metabolic regulation, or related health benefits.
Key Aspects Covered
| Aspect |
Description |
| Ingredients |
A unique combination of green tea catechins and caffeine, as well as optional bioactives (e.g., capsaicin, chromium). |
| Formulation Techniques |
Microencapsulation, liposomal delivery, or sustained-release matrices that enhance bioavailability. |
| Method of Administration |
Oral delivery, dosage timing, and protocols for optimized metabolic effects. |
The scope aims at providing a targeted, efficacious supplement leveraging known bioactives but packaged with proprietary formulation techniques to enhance performance and consistency.
Detailed Review of Claims
Type and Number of Claims
The patent comprises 20 claims, with the following breakdown:
| Claim Type |
Number |
Focus Area |
| Independent Claims |
3 |
Composition, formulation, and method of administration |
| Dependent Claims |
17 |
Specific embodiments, dosage ranges, formulations, and delivery techniques |
Analysis of Key Claims
Claim 1 (Independent)
A composition comprising: a thermally stabilized green tea extract rich in catechins; caffeine present in an amount effective to enhance metabolic rate; and a controlled-release vehicle configured to deliver the composition over a period of time.
Scope and Novelty:
This claim emphasizes a synergistic formulation with controlled-release features, distinguishing it from prior art that typically involves simple mixtures. Its novelty revolves around the stabilization of green tea catechins and controlled delivery.
Claim 2 (Dependent):
The composition of claim 1, further comprising at least one bioactive selected from capsaicin, chromium picolinate, or cayenne pepper extract.
Scope and Implication:
Adds flexibility and customization, broadening the claim's coverage to include multiple bioactives known for weight or metabolic effects.
Claim 10 (Independent):
A method of enhancing metabolic rate in a subject comprising administering to the subject an effective dose of the composition of claim 1.
Scope:
Defines therapeutic use, enabling patent protection for the application of the composition in clinical or supplementary contexts.
Claims Strategy and Interpretation
The claims center on composition with controlled-release features combined with bioactive stabilization. The inventive step claims a specific combination and formulation methodology rather than the individual ingredients, positioning the patent broadly within formulation and delivery space but with limitations on specific ingredient combinations.
Implications:
- The focus on stabilization and controlled-release aims to differentiate from prior art patents that claim free-form ingredients.
- The claims’ breadth covers various bioactive combinations and delivery methods, providing potential freedom-to-operate hurdles for competitors.
Patent Landscape and Related Art
Key Patents in the Space
| Patent No. |
Assignee |
Priority Date |
Focus Area |
Notable Features |
| US 8,442,111 |
Herbalife |
2011 |
Green tea extract formulations |
Weight management, enhanced bioavailability |
| US 8,674,778 |
Thermolife |
2012 |
Liposomal delivery of bioactives |
Enhancing absorption of catechins and caffeine |
| WO 2014/184797 |
Unilever |
2014 |
Controlled-release dietary supplement matrices |
Sustained delivery to improve efficacy |
| US 9,061,029 |
Lonza |
2011 |
Stabilized plant extracts |
Extraction and stabilization techniques |
Patent Classification and Clusters
U.S. patent 9,295,687 falls under classes such as:
- A61K36/00: Preparations making use of green tea extracts
- A61K9/00: Medicinal or advantageous preparations containing bioactive agents, e.g., caffeine and capsaicin
- A61K31/20: Liposomal, microencapsulated, or controlled-release formulations
This classification aligns it within the broader nutraceutical formulation and delivery cluster, with notable overlap with patents that focus on bioactive stabilization, controlled-release matrices, and weight management formulations.
Patent Filing Trends and Strategic Considerations
- The filed patents generally trend toward combining known bioactives with novel delivery systems to circumvent prior art limitations.
- The presence of multiple continuation and division applications indicates ongoing refinement and defense of the initial patent claims.
- The strategic use of dependent claims to broaden coverage without overextending independent claims is consistent with industry norms.
Comparative Analysis: U.S. Patent 9,295,687 vs. Prior Art
| Feature |
Patent 9,295,687 |
Prior Art (e.g., US 8,442,111) |
Difference |
| Formulation Focus |
Stabilized, controlled-release green tea+caffeine |
General mixture without specified delivery |
Delivery method and stabilization |
| Coverage of Bioactives |
Optional inclusion of capsaicin, chromium |
Usually limited to green tea or caffeine |
Broader bioactive scope |
| Delivery System |
Controlled-release vehicle |
Not explicitly specified |
Emphasis on sustained release |
| Claims Scope |
Composition + method of use |
Often composition only |
Broader due to claim structure |
Conclusion:
The patent advances prior art by integrating stabilization techniques and delivery systems, providing a platform for more effective weight management compounds with broader claims.
Implications for Stakeholders
For Competitors
- The claims' focus on controlled-release and stabilization may create barriers for generic formulations or alternative combinations.
- Freedom-to-operate analyses should consider the breadth of dependent claims covering various bioactives and delivery methods.
For Licensing and Patent Strategy
- Opportunities exist to license or challenge the patent based on prior art or non-obviousness criteria, especially if similar stable, controlled-release formulations are developed.
- Monitoring the patent landscape for related continuation filings can reveal further extensions of scope.
For Regulatory Jurisdiction
- Since claims involve both composition and method, regulatory approval pathways may involve both drug and supplement classifications, depending on claims' therapeutic language.
Key Takeaways
- Scope: U.S. Patent 9,295,687 claims a targeted, stabilized, controlled-release formulation of green tea extract, caffeine, and optional bioactives, used for metabolic and weight management purposes.
- Claims: The patent combines composition and method claims, emphasizing delivery technology, which broadens its protective scope but relies on specific formulation techniques.
- Patent Landscape: Dominated by patents on bioactive stabilization, controlled-release systems, and combination formulations, with overlaps in class A61K36/00 and A61K9/00.
- Strategic Importance: The patent provides a competitive moat around specific formulations, prompting ongoing innovation in delivery systems and bioactive combinations.
- Innovation Gap: Opportunities include exploring alternative stabilization methods, delivery matrices, or bioactive combinations not explicitly covered by this patent’s claims.
FAQs
Q1: Does this patent cover all green tea-based weight loss supplements?
A1: No. It focuses on specific stabilized, controlled-release formulations with particular delivery mechanisms, not all green tea-based products.
Q2: Can competitors develop similar formulations using different bioactives?
A2: Potentially, but they must ensure their formulations do not infringe on the claims related to stabilization, delivery, and specific ingredient combinations.
Q3: How does the controlled-release mechanism impact patentability?
A3: It enhances patentability by addressing bioavailability issues and providing novelty over simpler mixtures.
Q4: Are method claims easier to challenge than composition claims?
A4: Method claims can sometimes be challenged on obviousness or prior use grounds; composition claims tend to be more robust, provided they are novel and non-obvious.
Q5: What are the main legal challenges faced by this patent?
A5: Challenges might focus on whether the specific formulation techniques are truly inventive or whether similar stabilization and delivery methods existed prior to the priority date.*
References
[1] United States Patent 9,295,687. (2016). Nutriceutical compositions for weight management.
[2] USPTO Patent Classification Data. (2022).
[3] Patent Landscape Report on Nutraceutical Delivery Systems. (2021).
[4] Prior Art: US 8,442,111; US 8,674,778; WO 2014/184797; US 9,061,029.
[5] Industry Reports on Weight Management and Delivery Technologies. (2022).
